United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

waymade healthcare plc - olsalazine sodium - oral capsule - 250mg

Ireland - English - HPRA (Health Products Regulatory Authority)

atnahs pharma netherlands b.v. - olsalazine sodium - capsule, hard - 250 milligram(s) - aminosalicylic acid and similar agents; olsalazine

Ireland - English - HPRA (Health Products Regulatory Authority)

atnahs pharma netherlands b.v. - olsalazine sodium - tablet - 500 milligram(s) - aminosalicylic acid and similar agents; olsalazine

United States - English - NLM (National Library of Medicine)

american regent, inc. - polysulfated glycosaminoglycan (unii: 268aw7000t) (polysulfated glycosaminoglycan - unii:268aw7000t) - adequan® canine is recommended for intramuscular injection for the control of signs associated with non-infectious degenerative and/or traumatic arthritis of canine synovial joints. do not use in dogs showing hypersensitivity to psgag. psgag is a synthetic heparinoid; do not use in dogs with known or suspected bleeding disorders.

India - English - Central Drugs Standard Control Organization

cfl ph. - mucopolysaccharide poly sulfate(heparinoid) - crm - 250iu/g - 5g/14g

Israel - English - Ministry of Health

pfizer pfe pharmaceuticals israel ltd - dalteparin sodium - solution for injection - dalteparin sodium 5000 iu / 0.2 ml - dalteparin - dalteparin - prevention of clotting during haemodialysis and haemofiltration in connection with acute renal failure or chronic renal insufficiency. treatment of acute deep venous thrombosis and/or pulmonary embolism.unstable coronary artery disease. thromboprophylaxis in conjunction with surgery. prophylaxis in patients with substantially increased risk for venous thromboembolism and that are temporarily immobilized due to acute illness such as cardiac insufficiency respiratory insufficiency and severe infections.cancer patients : treatment and secondary prevention of deep-vein thrombosis and/or pulmonary embolism.

Israel - English - Ministry of Health

pfizer pfe pharmaceuticals israel ltd - dalteparin sodium - solution for injection - dalteparin sodium 2500 iu / 0.2 ml - dalteparin - dalteparin - prevention of clotting during haemodialysis and haemofiltration in connection with acute renal failure or chronic renal insufficiency. treatment of acute deep venous thrombosis and/or pulmonary embolism. unstable coronary artery disease. thromboprophylaxis in conjunction with surgery. prophylaxis in patients with substantially increased risk for venous thromboembolism and that are temporarily immobilized due to acute illness such as cardiac insufficiency respiratory insufficiency and severe infections.cancer patients : treatment and secondary prevention of deep-vein thrombosis and/or pulmonary embolism.

Israel - English - Ministry of Health

pfizer pfe pharmaceuticals israel ltd - dalteparin sodium - solution for injection - dalteparin sodium 2500 iu/ml - dalteparin - dalteparin - prevention of clotting during haemodialysis and haemofiltration in connection with acute renal failure or chronic renal insufficiency. treatment of acute deep venous thrombosis and/or pulmonary embolism. unstable coronary artery disease. thromboprophylaxis in conjunction with surgery. prophylaxis in patients with substantially increased risk for venous thromboembolism and that are temporarily immobilized due to acute illness such as cardiac insufficiency respiratory insufficiency and severe infections. cancer patients : treatment and secondary prevention of deep-vein thrombosis and/or pulmonary embolism.

Singapore - English - HSA (Health Sciences Authority)

dch auriga singapore - ropivacaine hcl - injection - 2 mg/ml - ropivacaine hcl 2 mg/ml

Singapore - English - HSA (Health Sciences Authority)

dch auriga singapore - ropivacaine hcl - injection - 10 mg/ml - ropivacaine hcl 10 mg/ml